Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,188.40
+2.10 (0.18%)
Dec 31, 2025, 12:50 PM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.